跳至主要内容
临床试验/NCT05749757
NCT05749757尚未招募不适用

The Efficacy and Safety of Acupuncture for Post COVID-19 Fatigue: a Randomized Controlled Trial

Guang'anmen Hospital of China Academy of Chinese Medical Sciences0 个研究点目标入组 84 人开始时间: 2023年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
84
主要终点
The change from baseline in the Chalder Fatigue Scale (CFS) score

研究概览

简要总结

The aim of the study is to access the efficacy and safety of acupuncture for post COVID-19 fatigue.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients aged between 18 and
  • Confirmed COVID-19 infection in the past four weeks to six months, and a negative RT PCR and/or Antigen-Based Rapid Test at present.
  • A main complaint of fatigue emerged newly following COVID-19 infection.
  • A score of ≥15 on Chalder Fatigue Scale (CFS, score range 0-33).
  • Participating the trial volunteerly and providing written informed consent.

排除标准

  • Severe anxiety and depression: a score of ≥25 on 17-item Hamilton Rating Scale for Depression (HAMD-17) and/or a score scores >29 on 14-item Hamilton Rating Scale for Anxiety (HAMA-14).
  • Significant cognitive dysfunction or suicidal tendency.
  • Usage of anti-anxiety and/or anti-depression treatments over the last three months.
  • Previously diagnosed hypothyroidism or chronic fatigue syndrome.
  • A complication of serious and poorly controlled underlying diseases.
  • Having symptoms indicating emergency or severe conditions.
  • Concurrent use of other anti-fatigue agents or treatments at present.
  • Impaired walking ability.
  • Pregnant and/or lactating or planning to get pregnant in the next 4 months.

结局指标

主要结局

The change from baseline in the Chalder Fatigue Scale (CFS) score

时间窗: Week 4

CFS evaluates physical and mental fatigue with two subscales and 11 items. Total fatigue score is obtained by summing 11 items, which were rated on a four-point Likert scale (0=better than usual, 1=no worse than usual, 2=worse than usual, and 3=much worse than usual). Higher scores indicate more severe fatigue.

次要结局

  • Proportion of participants with a score of less than 15 on CFS(Weeks 4, 8, 12, and 16)
  • The change from baseline in the distance of Six-Minute Walk Test (6MWT).(Weeks 4, 8 and 16)
  • The proportion of participants rated as "very much improved" or "much improved" based on the Patient Global Impression-Change (PGI-C).(Weeks 4, 8, 12, and 16)
  • The change from baseline in the score of Chinese Version of the Work and Social Adjustment Scale (CWSAS).(Weeks 4, 8, 12, and 16)
  • The change from baseline in the score of Physical Health Questionnaire-9 (PHQ-9)(Weeks 4 and 16)
  • The change from baseline in the score of General Anxiety Disorder-7 (GAD-7).(Weeks 4 and 16)
  • The change from baseline in the score of Insomnia Severity Index (ISI).(Weeks 4, 8, 12, and 16)
  • The change from baseline in the Chalder Fatigue Scale (CFS) score(Weeks 8, 12, and 16)
  • The change from baseline in the score of physical function dimension of Medical Outcomes Study 36-item Short-Form General Health Survey (SF-36).(Weeks 4, 8, 12, and 16)
  • The change from baseline in the score of Montreal Cognitive Assessment (MoCA).(Weeks 4 and 16)
  • The change from baseline in the score of Patient Health Questionnaire-15 (PHQ-15) score.(Weeks 4 and 16)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Yuanjie Sun

Principal Investigator

Guang'anmen Hospital of China Academy of Chinese Medical Sciences

相似试验